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Abstract 
Background: Zanthoxylum heitzii (Rutaceae) (olon) is used in traditional medicine in Central and West Africa to treat 
malaria. To identify novel compounds with anti-parasitic activity and validate medicinal usage, extracts and com-
pounds isolated from this tree were tested against the erythrocytic stages of the human malaria parasite Plasmodium 
falciparum and for inhibition of transmission in rodent malaria parasite Plasmodium berghei.
Results: Hexane bark extract showed activity against P. falciparum (IC50 0.050 μg/ml), while leaf and seed extracts 
were inactive. Fractionation of the hexane bark extract led to the identification of three active constituents; dihydron-
itidine, pellitorine and heitziquinone. Dihydronitidine was the most active compound with an IC50 value of 0.0089 µg/
ml (25 nM). This compound was slow acting, requiring 50 % longer exposure time than standard anti-malarials to 
reach full efficacy. Heitziquinone and pellitorine were less potent, with IC50 values of 3.55 μg/ml and 1.96 µg/ml, but 
were fast-acting. Plasmodium berghei ookinete conversion was also inhibited by the hexane extract (IC50 1.75 µg/ml), 
dihydronitidine (0.59 µg/ml) and heitziquinone (6.2 µg/ml). Water extracts of Z. heitzii bark contain only low levels of 
dihydronitidine and show modest anti-parasitic activity.
Conclusions: Three compounds with anti-parasitic activity were identified in Z. heitzii bark extract. The alkaloid dihy-
dronitidine is the most effective of these, accounting for the bulk of activity in both erythrocytic and transmission-
blocking assays. These compounds may present good leads for development of novel anti-malarials and add to the 
understanding of the chemical basis of the anti-parasitic activity in these classes of natural product.
Keywords: Zanthoxylum heitzii, Rutaceae, Dihydronitidine, Anti-malarial, Benzophenanthridine alkaloid, Ookinete, 
Transmission blocking, Malaria, Ethnobotany
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Background
In many African countries with high rates of malaria 
transmission, there is a common tradition of using native 
plants to treat malaria. The most seriously affected 
countries are associated with a dysfunctional health sys-
tem and poverty [1], and accessibility to anti-malarial 
treatment is often inadequate or non-existent. Where 
available, free artemisinin combination therapy (ACT) 
is limited to pregnant women and children under 5 years 
of age [1], making expenditure on malaria treatment a 
huge burden for middle-income households and essen-
tially unaffordable for most of the population who live 
on less than $2 a day [2]. Substandard and counterfeit 
anti-malarials are also major concerns and contribute 
to drug resistance [3, 4]. Use of herbal anti-malarials in 
sub-Saharan Africa is widespread, although the reported 
prevalence varies considerably. A meta-analysis from 
2004 indicates an overall prevalence of 24 %, but regional 
use varied from 0 to 75 % [5]. Use of traditional medicine 
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is most prevalent in rural and poor areas where it plays 
a very important role for disease control [6]. Traditional 
medicines have provided the basis for highly effective 
anti-malarials: the quinine and artemisinin derivatives. 
With resistance to artemisinin derivatives currently on 
the rise [7], identifying novel anti-malarials and under-
standing the efficacy of traditional remedies is of increas-
ing importance.
Members of the genus Zanthoxylum are widely used as 
traditional medicines for the treatment and prevention 
of malaria [8–10]. Zanthoxylum spp. are well known for 
producing an array of complex secondary metabolites, 
especially benzophenanthridine alkaloids, some of which 
have previously been shown to have anti-malarial activ-
ity [11–14]. The in  vitro efficacy of these compounds 
lends support for their use in traditional medicine. The 
tree Zanthoxylum heitzii (syn. Fagara heitzii), grows 
over a range that encompasses many areas of high 
malaria transmission in Central-West Africa [10]. In 
this area, the bark is traditionally used to treat malaria 
[10]. Zanthoxylum heitzii bark extracts and major com-
ponents of the extracts have previously been shown to 
have insecticidal activity [16–18] but it is unknown if Z. 
heitzii contains any compounds with significant anti-
parasitic activity.
This paper investigates the activity of extracts and 
chemical components isolated from Z. heitzii against 
the malaria parasites, Plasmodium falciparum and Plas-
modium berghei to investigate the scientific rationale 
behind the traditional use against malaria. Fractiona-
tion and in  vitro testing against P. falciparum identified 
three compounds with significant anti-parasitic activity, 




Stem bark, seeds and leaves of Zanthoxylum heitzii 
(Rutaceae) were harvested in Douakani, Republic of 
Congo during November 2011. Voucher samples are 
kept in the Section of Pharmacognosy, School of Phar-
macy, University of Oslo, registry number ZH-B-111202 
(bark), ZH-L-111201 (leaf ) and ZH-S-111203 (seed). 
This work was carried out in accordance with the Nagoya 
convention.
Extraction and isolation of natural compounds
The plant material was extracted and natural products 
isolated according to Moussavi et  al. [18] and Wangen-
steen et al. [19]. Briefly, the stem bark, seeds and leaves 
were air dried and made into a powder (<1  mm). The 
powdered plant materials were first extracted with 
hexane in a Soxhlet extractor until the effluent was color-
less, and then subsequently extracted with ethyl acetate 
and ethanol in an accelerated solvent extractor, ASE350 
(Dionex) [17]. The pure compounds were obtained from 
the bark hexane extract as previously described [18, 19] 
by Si-gel normal phase and reverse phase C18 chroma-
tography. The powdered bark (<1 mm), 10 g, was mixed 
with 100  g water and refluxed for 20  min to mimic a 
common way of preparing herbal drugs, making a decoc-
tion. The decoction was filtered through glass wool when 
hot and lyophilized in aliquots of 1  ml, corresponding 
to ~10 mg dry weight.
Quantification of dihydronitidine
The dihydronitidine content in hexane, ethyl acetate 
(EtOAc) and ethanol (EtOH) extracts from bark, leaf 
and seeds, as well as boiling water extract of the bark, 
was quantified by C18-HPLC. The dried extracts were 
dissolved by sonication (10  min) in acetonitrile (final 
concentration 1–10  mg/ml). The solutions were fil-
tered (PTFT membrane, 0.22  µm) and the filtrate, 
40 μl, was applied on a Chromolith Performance RP18e 
100  ×  4.6  mm HPLC column (Merck) attached to 
LaChrom Elite HPLC system (VWR-Hitachi) equipped 
with an L-2455 diode array detector. Elution was per-
formed using a gradient of mobile phase A (20  mM 
ammonium acetate) and mobile phase B (acetonitrile) 
with the following time schedule: 20  % B, 0–1  min; 
20–90 % B, 1–15 min; 90 % B, 15–16 min. The flow rate 
was 3.0 ml/min. The absorbance was recorded at 278 and 
312 nm, and separation took place at 25 °C.
Purity of dihydronitidine
The purity of dihydronitidine was estimated to be bet-
ter than 97  % from 1H NMR spectroscopy (Additional 
file  1). Signals from nitidine were not detectable, and it 
was therefore assumed that dihydronitidine used in the 
in vitro assays was nitidine free. Dihydronitidine isolated 
from the hexane bark extract [18] was used in all assays.
Stability of dihydronitidine in in vitro culture media
Dihydronitidine (5 µl, 10 mg/ml in DMSO) was added to 
0.5  ml of RPMI 1640 complete medium supplemented 
with sodium bicarbonate (0.18 %) and FBS (0.5 %)(Gibco) 
and incubated in triplicates at 37 °C for 0, 24, 48 and 72 h 
(final concentration of dihydronitidine 100  µg/ml). The 
solution was taken to dryness in a SpeedVac vacuum 
concentrator (Thermo Scientific) and subsequently dis-
solved in 1 ml acetonitrile and sonicated for 10 min. The 
filtrate, 40 μl, was analysed by HPLC as described above 
(Quantification of dihydronitidine). Nitidine chloride 
(Sigma) was used as standard.
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Anti‑parasitic activity in Plasmodium falciparum
The chloroquine susceptible strain 3D7 and the chlo-
roquine resistant strain Dd2 parasites were cultured 
according to existing protocols [20]. In  vitro assays are 
based on the method of Smilkstein et al. [21] as modified 
by Goodman et  al. [22]. In assays longer than 72  h, the 
medium was changed after 72 h of parasite growth. For 
tests of dihydronitidine stability, drug was diluted in cul-
ture media as per standard assay protocol but incubated 
at 37  °C for 24  h prior to initiation of in  vitro assay by 
addition of parasites and blood. Fluorescence was meas-
ured using an Enspire fluorescent plate reader (Perkin 
Elmer).
Transmission blocking assay (ookinete conversion assay)
To assay inhibition of the early mosquito stages of par-
asite development, P. berghei gametocytes expressing 
green fluorescence protein (GFP) under the control of 
the ookinete specific promoter CTRP were induced to 
undergo in  vitro fertilization and subsequent develop-
ment to ookinete stage in a standard 96-well plate assay, 
essentially as described [23]. Successful development to 
ookinete stage was assayed by GFP fluorescence meas-
ured using an Enspire fluorescent plate reader (Perkin 
Elmer).
Statistical analysis
Relative fluorescence was corrected for background and 
normalized to untreated controls to generate values in 
percent parasitaemia. Drug concentrations were con-
verted to a log scale prior to analysis. Each in vitro assay 
was done in triplicate and IC50 values calculated using 
the four component model available in the Prism 6 statis-
tical package (GraphPad). Mean and standard error val-
ues were calculated from three independent assays unless 
otherwise stated.
Results and discussion
Activity against Plasmodium falciparum in vitro cultures
Extracts from the bark, leaf and seeds were screened for 
activity against P. falciparum in 48 h in vitro drug assays. 
The greatest activity was seen in bark extracts, regard-
less of the solvent, with hexane extracting the most active 
substances (Fig.  1). Leaf and seed extracts showed little 
to no anti-parasitic activity, so further analysis focused 
on the hexane extract of the bark. The bark extract was 
fractionated and the fractions tested for activity against 
P. falciparum (Additional file 2). The major components 
of the active fractions were purified and identified (Fig. 2) 
and further tested for anti-parasitic activity. The puri-
fied compounds dihydronitidine, heitziquinone and pel-
litorine (Fig. 2) showed significant anti-parasitic activity 
(Table  1), with dihydronitidine being the most active 
compound (IC50 of 0.0089 ± 0.0008 µg/ml).
Standard in  vitro assays measuring anti-parasitic 
effects after 48  h exposure to dihydronitidine showed 
IC50 values of 0.3 µg/ml, which are similar to published 
IC50 values for dihydronitidine [13, 24], but with an unu-
sually flat dose response (Fig. 3a) suggesting a slow act-
ing drug effect. To investigate this, assays were extended 
with drug exposure time to 72 and 120 h. With 72 h of 
exposure, the IC50 was significantly lower (Table  1) and 
the drug response curves showed a typical dose response 
(Fig. 3b). Further increasing the length of drug exposure 
did not impact the effective concentration (Fig. 3b), pre-
cluding the possibility of “delayed death” drug response 
common to compounds targeting the parasite apicoplast 
[22]. Subsequent assays with hexane extracts of bark over 
72 h revealed a significant reduction in effective concen-
tration (compare Fig.  1 and Table  1), reflecting the fact 
that dihydronitidine comprises a significant proportion 
of the anti-parasitic activity of the extract.
Two other compounds extracted from Z. heitzii 
showed activity against P. falciparum; pellitorine and the 
recently reported alkaloid heitziquinone [19] (Table  1). 
These compounds were less active, with IC50 values of 
1.96 ± 0.12 and 3.55 ± 0.62 µg/ml respectively, but were 
fast acting, having normal dose response curves with 48 h 
of drug exposure (Fig. 3a) and no change in effective con-
centration with extended drug exposure. The observed 
IC50 for pellitorine (1.96  µg/ml) is similar to previously 
reported values [25].
Two of the three active compounds are benzophen-
anthridine alkaloids, and previous studies show that the 
anti-malarial activity of this class of compounds is very 
sensitive to even small changes in chemical structure [26]. 
Heitziquinone has an opened C-ring and is, therefore, to 
the knowledge of the authors, the first open C-ring ben-
zophenanthridine alkaloid that shows anti-plasmodial 
activity. This suggests that a closed C-ring is not essential 
for activity and that the structure–activity relationship 
in benzophenanthridine alkaloids is complex. A greater 
range of benzophenanthridine alkaloid compounds will 
need to be tested to elucidate these relationships.
Stability of dihydronitidine
The simplest explanation for the slow acting nature of 
dihydronitidine is the progressive breakdown of this 
compound under culture conditions to products that 
have greater anti-parasitic activity. Nitidine, a possible 
product of dihydronitidine oxidation, is thought to be the 
main active ingredient in several traditional anti-malarial 
remedies used in other parts of the world [13, 27]. The 
reported IC50 values for nitidine in standard assays (48 h) 
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vary considerably [13, 26–28] but the lowest values fall in 
a similar range to those found for dihydronitidine in the 
long-exposure assays (72  h). It was reported previously 
that dihydronitidine may be slowly oxidized to nitidine 
under aerobic conditions [28]. To test its stability under 
culture conditions, dihydronitidine was incubated in 
parasite growth medium for 72 h at 37  °C and analysed 
at 24  h intervals to identify any breakdown products. 
Even prolonged incubation over 72 h did not significantly 
reduce the concentration of dihydronitidine in the sam-
ple (Fig.  4a) nor result in the production of detectable 
levels of nitidine. To further test whether dihydroniti-
dine, and not its breakdown products, are responsible 
for the observed anti-parasitic activity, dihydronitidine 
was diluted in culture media in a 96 well plate accord-
ing to the in vitro assay protocol and incubated at 37 °C 
for 24 h. Parasites were then added to initiate the in vitro 
assay and anti-parasitic activity was tested after 48 h. Pre-
incubation had little effect on the slow acting nature of 
dihydronitidine (Fig. 4b) suggesting that dihydronitidine, 
and not its breakdown products, is responsible for the 
observed anti-parasitic effects.
Fig. 1 In vitro activity against P. falciparum of crude extracts isolated from leaf, bark and seed of Z. heitzii. Mean of three technical replicates ± stand-
ard deviation. EtOAc ethyl acetate; EtOH ethanol
Fig. 2 Benzophenanthridine alkaloids and pellitorine isolated from Z. heitzii [18, 19]. *Nitidine is included for structure comparison and was not 
present in the hexane extract
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The structural similarity between nitidine and dihy-
dronitidine suggests that these compounds may share a 
mechanism of action. In this case, we would expect niti-
dine to show slow acting response similar to dihydroniti-
dine. However, the observed activity of nitidine over 72 h 
(Table  1) was consistent with previously reported effec-
tive concentrations reported for shorter drug exposures 
[13, 27]. This agrees with the chemical characteristics of 
the compounds. While nitidine was suggested to act by 
binding to DNA [24], it was later reported that nitidine 
forms a 1-1 complex with haem in vitro and also inhibits 
β-haematin formation with the same potency as chloro-
quine [27], so it has been postulated that nitidine activ-
ity is similar to chloroquine; interfering with haemozoin 
formation in the food vacuole. Haem binding activity 
requires a positive charge, and with its quaternary nitro-
gen, nitidine will always be charged. Dihydronitidine, 
however, will not be charged at the pH of the food vacuole 
(pH 4.5–4.9 [29]) due to its low calculated Pkb of 2.8. This 
suggests that the slow-acting characteristic of dihydroniti-
dine reflects a different mechanism of action between the 
two compounds. Encouragingly, neither nitidine [26] nor 
dihydronitidine show chloroquine cross-resistance, with 
the resistance index (Dd2/3D7) of 1.7  ±  0.06 for dihy-
dronitidine and 1.26 ± 0.20 for nitidine being significantly 
lower than the 10.0 ± 0.17 observed for chloroquine.
Effects on mosquito stages of parasite development
To examine transmission blocking activity, Z. heitzii bark 
hexane extract, dihydronitidine, heitziquinone and pel-
litorine were tested on mosquito stages of the malaria 
parasite life cycle for their ability to block ookinete for-
mation in P. berghei (ANKA strain). As in blood stages, 
dihydronitidine showed the greatest activity, although it 
was far less potent against this stage of the parasite life 
cycle (Table 2). Heitziquinone had similar levels of activ-
ity against both stages but pellitorine did not inhibit 
ookinete development in  vitro. This suggests that both 
dihydronitidine and heitziquinone target parasite path-
ways that are active early in the insect stages of the para-
site life cycle and have transmission blocking activity.
Traditional use and water extractability of active 
compounds
Available ethnobotanical surveys [10] indicate that bark 
is the only plant part from Z. heitzii, locally known as 
olon in the Republic of Congo, used for treating malaria. 
The presented results clearly show that the bark is more 
active compared to leaves and seeds, hence the rationale 
Table 1 Inhibitory activity of  hexane bark extract of  Z. 
heitzii and  pure compounds isolated from  the extract 
against P. falciparum in 72 h assays




Hexane bark extract 0.050 ± 0.004 N/A
Dihydronitidine 0.0089 ± 0.0008 0.025 ± 0.002
Pellitorine 1.96 ± 0.12 8.8 ± 0.5
Heitziquinone 3.55 ± 0.62 9.7 ± 1.6
Sesamin >10 >28
Isobauerenol >10 >23
Caryophyllene oxide >10 >49
Rhoifoline B >10 >28
Isoarnottianamide >10 >26
Nitidinea 0.038 ± 0.002 0.099 ± 0.050
WR 99210a 3.167 × 10−6 1.2 × 10−5
Fig. 3 The slow acting characteristics of dihydronitidine. a Dose–response curves for P. falciparum (3D7) in 48 h in vitro drug assays showing unu-
sual response to dihydronitidine. b Response of parasites to increasing time of dihydronitidine exposure. Maximum efficacy is reached at 72 h, with 
no improvement with longer exposures
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behind using the bark as medicine is in accordance with 
in  vitro activity. Dihydronitidine being the main active 
constituent in Z. heitzii is supported by the low anti-par-
asitic potency of the seed and leaf extracts, which do not 
contain dihydronitidine (Additional file 3).
Traditional herbal medicines are often prepared as 
boiled water extracts (decoctions) and this is a common 
way of preparing extracts of many Zanthoxylum spp. 
used as anti-malarials [11, 15]. There is, however, little 
literature available describing preparations of Z. heitzii 
bark for use as an anti-malarial beyond a single report 
describing the dermal application of bark scrapings [10]. 
To explore the efficacy of Z. heitzii bark extracted as a 
traditional decoction, the levels of active compounds 
extracted and the in  vitro anti-parasitic activity of the 
decoction were examined.
The dihydronitidine content in the hexane bark 
extract was 25.9  ±  2.4  % (HPLC), corresponding to 
ca. 0.6  % of the dried bark. The decoction, however, 
extracted low levels (~2 %) of the bark content of dihy-
dronitidine; yielding a final concentration in the decoc-
tion of 10.7  ±  0.8  µg/ml. Other components that were 
extracted into boiling water were pellitorine and sesamin 
(Additional file  4). Pellitorine showed a relatively low 
anti-malarial activity, (IC50 1.96  µg/ml), and sesamin 
was inactive (Table 1). Sesamin, however, has previously 
been shown to enhance activity of other compounds due 
to inhibition of CYP3A enzymes involved in compound 
metabolism [30] and this may increase the anti-malarial 
potency of dihydronitidine in vivo.
The activity of the lyophilized decoction against P. fal-
ciparum in  vitro was tested. The low dihydronitidine 
content in a decoction of Z. heitzii bark was manifest in 
the low anti-parasitic activity. When tested against P. fal-
ciparum (3D7) in  vitro, the decoction was only weakly 
effective, with an IC50 of 9.6 ± 1.5 µg/ml. While far less 
effective than the purified compounds, this does sug-
gest that the decoction may provide a minimal amount 
of anti-parasitic activity due to the small amount of dihy-
dronitidine, pellitorine and heitziquinone, and possible 
synergistic activity among them.
It is not entirely surprising that there is little dihy-
dronitidine in the water decoction of Z. heitzii as dihy-
dronitidine is very hydrophobic, with a calculated log S 
(octanol–water partitioning constant) of −4.63 at pH 7 
(ACD/Labs). This makes it difficult to extract dihydron-
itidine using boiling water. Often in traditional medi-
cine, a decoction is acidified using lemon juice. This is 
may be done to provide a more palatable taste but it also 
protonates the basic nitrogen often found in many alka-
loids, improving their solubility in water. Dihydroniti-
dine, however, has a calculated pKb of 2.8 ± 0.9 (ACD/
Labs), suggesting it would be largely refractory to this 
treatment. This suggests that the decoction method is 
not ideal for preparing Z. heitzii as an anti-malarial, in 
contrast to a number of Zanthoxylum spp. containing 
similar, but water-soluble quaternary benzophenanthri-
dine alkaloids.
Fig. 4 Dihydronitidine is stable under culture conditions. a Concentration of dihydronitidine after incubation in in vitro culture media at 37 °C 
showing minimal breakdown over 72 h. b Incubation of dihydronitidine in culture media for 24 h does not improve efficacy (mean/SD of three 
technical replicates)
Table 2 Inhibitory activity of Z. heitzii hexane bark extract, 
dihydronitidine, heitziquinone and  pellitorine against  P. 
berghei ANKA ookinete formation
Results are the mean of three biological replicates ± SEM
IC50 IC50
(μg/ml) (µM)
Hexane bark extract 1.75 ± 0.42 N/A
Dihydronitidine 0.59 ± 0.10 1.7 ± 0.29
Heitziquinone 6.20 ± 1.76 17.0 ± 4.8
Pellitorine >20 >20
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Conclusion
Zanthoxylum heitzii bark contains three compounds, 
dihydronitidine, pellitorine, and heitziquinone, with sig-
nificant activity against P. falciparum in in  vitro assays. 
Two of these compounds, dihydronitidine and heitziqui-
none, also show transmission-blocking activity against P. 
berghei. The most effective compound, dihydronitidine, 
is active in the low nM range and may be considered a 
lead molecule for drug development. The relatively poor 
extractability of dihydronitidine limits its concentrations 
in water preparations of Z. heitzii, suggesting that using 
preparations with non-polar extraction methods involv-
ing oil or fat, or simply using the powdered bark, could 
improve the anti-malarial characteristics of this tradi-
tional medicine.
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